GIVA is set to secure $12 million in an extended Series C funding round led by HPV CC1 Ltd

SUMMARY
The omnichannel jewelry company GIVA of Bengaluru is poised to significantly empower its financial position by increasing its capital to around ₹110 crore (approximately $12 million) in a stretched Series C funding round. This new inflow of capital is timely when the company is actively developing its presence in India. The investment round is led by HPV CC1 Ltd, with the presence of some high-profile existing and new investors such as Premji Invest, Kenro Capital, and Titan Capital.
Investment breakdown and valuation
As recent regulatory filings submitted by the company to the Registrar of Companies (RoC) have indicated, the board of GIVA has resolved to issue 9,401,710 Series C1 Compulsorily Convertible Preference Shares (CCPS). In order to raise this desired amount, these shares are being sold at a cost of ₹117 each. The tranche is being led by HPV CC1 Ltd with a substantial contribution of ₹74.25 crore (approximately $8.25 million).
Kenro Capital is also injecting primary capital of ₹13.75 crore in the round. In addition, Premji Invest, under its PI Opportunities Fund II, and Titan Capital, under its Winners Fund, are adding ₹11 crore each to the extension. This new capital follows about nine months after the startup, which had raised a total of ₹530 crore ($61.5 million) in its principal Series C round headed by Creaegis in June of last year.
The startup valuation has increased significantly as a result of the new investment. It is estimated that the valuation of GIVA has increased to about ₹4,900 crore ($545 million). This is a 22% growth against its earlier valuation of approximately ₹4,000 crore, which it had been valued at in the primary Series C infusion. It is also suggested that the current round will have a secondary transaction, which could be led by Kenro Capital.
Financial performance and fund utilization
GIVA will use the new proceeds to invest in some priority operational and expansionary domains. The company has indicated that the funds will be allocated to general operational costs, which include aggressive recruitment in all departments and massive marketing programs to create brand awareness. The capital will also promote the overall corporate needs and additional business initiatives that will seek to expand the reach of the brand.
There has been a substantial increase in the performance of the jewelry brand at the top line. In the fiscal year ending in March 2025 (FY25), GIVA registered a 89% increase in operating revenue, which recorded ₹518 crore, as compared to ₹274 crore in FY 24. The ambition to expand fast has also been accompanied by higher expenses since the losses of the firm have increased by 22% to ₹72 crore in the same period. The firm has so far collected more than a total of $146 million in capital.
GIVA is a jewelry company that is in a fiercely competitive new-age environment. It is one of the main competitors of BlueStone, which recently began trading publicly in August 2025 and has a projected revenue of ₹1,770 crore in FY25. CaratLane, also a significant player operating under the umbrella of Titan Company Limited, announced gigantic revenues of ₹3,583 crore and a network of more than 350 stores. Recent funding in the sector is also indicative of an active and capital-intensive environment, with other emerging players like Palmonas and Firefly Diamonds also getting funding recently.
Conclusion
The success of the Series C extension is indicative of investor confidence in GIVA and its omnichannel strategy and product diversification. With this additional funding of $12 million, the company is in a strong position to keep expanding into gold and lab-grown diamond segments, as well as increasing its number of retail stores.
Even though the startup is still experiencing increasing losses in its bid to dominate the market, its high revenue growth rate and the upward valuation indicate that GIVA will still be a force to reckon with in the changing jewelry market in India.
Note: We at scoopearth take our ethics very seriously. More information about it can be found here.